American Journal of Kidney Diseases
Volume 54, Issue 2 , Pages 299-306 , August 2009

Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Bare-Metal Stents in Hemodialysis Patients

  • Sen Yachi, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Kengo Tanabe, MD, PhD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
    • Corresponding Author InformationAddress correspondence to Kengo Tanabe, MD, PhD, Division of Cardiology, Mitsui Memorial Hospital, 1, Kandaizumi-cho, Chiyoda-ku, Tokyo, Japan
  • ,
  • Shuzou Tanimoto, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Jiro Aoki, MD, PhD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Gaku Nakazawa, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Hirosada Yamamoto, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Shuji Otsuki, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Atsuhiko Yagishita, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Satoru Kishi, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Masataka Nakano, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Masahiro Taniwaki, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Shunsuke Sasaki, MD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Hiroyoshi Nakajima, MD, PhD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Naofumi Mise, MD, PhD

      Affiliations

    • Division of Nephrology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Tokuichiro Sugimoto, MD, PhD

      Affiliations

    • Division of Nephrology, Mitsui Memorial Hospital, Tokyo, Japan
  • ,
  • Kazuhiro Hara, MD, PhD

      Affiliations

    • Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan

Received 18 August 2008 ,Accepted 30 January 2009.

References 

  1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  3. Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110–1115
  4. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  5. Daemen J, Lemos P, Aoki J, et al. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-Year clinical follow-up of a consecutive series of cases. J Invasive Cardiol. 2004;16:685–687
  6. Hassani SE, Chu WW, Wolfram RM, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol. 2006;18:273–277
  7. Nakazawa G, Tanabe K, Aoki J, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv. 2007;69:808–814
  8. Mishkel GJ, Varghese JJ, Moore AL, Aguirre F, Markwell SJ, Shelton M. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol. 2007;19:331–337
  9. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol. 2006;18:577–583
  10. Das P, Moliterno DJ, Charnigo R, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol. 2006;18:405–408
  11. Nakazawa G, Tanabe K, Aoki J, et al. Clinical and angiographic outcomes of sirolimus-eluting stent implantation in Japanese patients in daily practice. Circ J. 2006;70:1367–1371
  12. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation. 1999;100:1872–1878
  13. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115:2344–2351
  14. Le Feuvre C, Dambrin G, Helft G, et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol. 2000;85:1365–1368
  15. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207–2211
  16. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  17. Blacher J, London GM, Safar ME, Mourad JJ. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertens. 1999;17:237–244
  18. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty (A practical proliferative model in porcine coronary arteries). Circulation. 1990;82:2190–2200
  19. Hoffmann R, Mintz GS, Mehran R, et al. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol. 1999;83:1170–1174
  20. Sabo RS, Bartoli F, Apitz-Castro R. In vivo platelet hyperreactivity, another risk factor for patients under continuous ambulatory peritoneal dialysis. Nephron. 1988;49:228–230
  21. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron. 1986;43:139–143
  22. Notohamiprodjo M, Andrassy K, Bommer J, Ritz E. Dialysis membranes and coagulation system. Blood Purif. 1986;4:130–141
  23. Lin YF, Chang DM, Shaio MF, et al. Cytokine production during hemodialysis: Effects of dialytic membrane and complement activation. Am J Nephrol. 1996;16:293–299
  24. Schettler V, Wieland E, Methe H, Schuff-Werner P, Muller GA. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant. 1998;13:2588–2593
  25. Horl WH, Steinhauer HB, Schollmeyer P. Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranes. Kidney Int. 1985;28:791–796
  26. Aoyama T, Ishii H, Toriyama T, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J. 2008;72:56–60
  27. Popma JJ, Leon MB, Moses JW, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004;110:3773–3780
  28. Ishio N, Kobayashi Y, Takebayashi H, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J. 2007;71:1525–1529

 Originally published online as doi: 10.1053/j.ajkd.2009.01.263 on April 27, 2009.

PII: S0272-6386(09)00435-1

doi: 10.1053/j.ajkd.2009.01.263

American Journal of Kidney Diseases
Volume 54, Issue 2 , Pages 299-306 , August 2009